A case of diazoxide unresponsive congenital hyperinsulinemic hypoglycemia with missense mutation in ABCC8 gene
DOI:
https://doi.org/10.18203/2349-3291.ijcp20230444Keywords:
Congenital hyperinsulinemia, ABCC8 gene mutation, Diazoxide, HypoglycemiaAbstract
Hypersecretion of insulin by pancreatic ß-cells causes hypoglycemia called congenital hyperinsulinism (CHI). It can inhibit brain development in infants. It is associated with mutations in the ABCC8 or KCNJ11 genes encoding for the SUR1 and KIR 6 (subunits of the ATP-sensitive potassium (KATP channel) a rare genetic disorder. It has an incidence rate of 1 in 50,000 in general populations and 1 in 2000 in areas with a higher rate of consanguinity. Here, we report a case of hyperinsulinemic hypoglycemia with ABCC8 gene mutation in a late preterm female infant who developed late-onset hypoglycemia. The infant developed hypoglycemic seizures on day 3 of life and her metabolic workup revealed hyperinsulinemia. A high glucose infusion rate and enteral feeding could not maintain the infant's serum glucose level. PET scan showed no abnormal somatostatin receptor avid lesion in pancreatic parenchyma. Hence genetic workup was done which showed a missense mutation in the ABCC8 gene which was c.4154C>G/p.Ser1385Cys. Over 9 months of follow-up, the infant is treated with octreotide and diazoxide, hasn't had any hypoglycemic events and has normal growth and psychomotor development for her age.
References
Hussain S, Flanagan S, Ellard S. A Case Report on Congenital Hyperinsulinism Associated with ABCC8 Nonsense Mutation: Good Response to Octreotide. J ASEAN Federation Endocrine Soc. 2016;31(2):178.
Stanley CA. Perspective on the genetics and diagnosis of congenital hyperinsulinism disorders. J Clin Endocrinol Metab. 2016;101(3):815-26.
Hussain K. Insights in congenital hyperinsulinism. Endocr Dev. 2007;11:106-21.
Meissner T, Mayatepek E. Clinical and genetic heterogeneity in congenital hyperinsulinism. Eur J Pediatr. 2002;161(1):6-20.
Hussain K, Aynsley-Green A, Stanley CA. Medications used in the treatment of hypoglycemia due to congenital hyperinsulinism of infancy (HI). Pediatr Endocrinol Rev. 2004;2(1):163-7.
Grimberg A, Ferry RJ, Kelly A, Koo-McCoy S, Polonsky K, Glaser B, et al. Dysregulation of insulin secretion in children with congenital hyperinsulinism due to sulfonylurea receptor mutations. Diabetes. 2001;50(2):322-8.
Park K, Lim KI, Sohn YB, Lee HS, Hwang JS. Case report describing a patient with diazoxide resistant congenital hyperinsulinism resulting from compound heterozygous mutations in the ABCC8 gene. Ann Pediatr Endocrinol Metab. 2022;10.
Thakur S, Flanagan SE, Ellard S, Verma IC. Congenital hyperinsulinism caused by mutations in ABCC8 (SUR1) gene. Indian Pediatr. 2011;48(9):733-4.
Kliegman R Stanton B St Geme JW Schor NF Behrman RE Nelson WE. Nelson Textbook of Pediatrics. Edition 21 ed. Philadelphia PA: Elsevier. 2020.
Eichenwald EC Hansen AR Martin C Stark AR. Cloherty and Stark's Manual of Neonatal Care. Eighth edition. Philadelphia: Wolters Kluwer. 2017.
